Status:
UNKNOWN
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
Lead Sponsor:
Amsterdam UMC, location VUmc
Conditions:
COVID-19
Hypoxemic Respiratory Failure
Eligibility:
All Genders
18+ years
Brief Summary
Coronavirus disease (COVID-19) can result in severe hypoxemic respiratory failure that ultimately may require invasive mechanical ventilation in the Intensive Care Unit (ICU). Although lifesaving, inv...
Eligibility Criteria
Inclusion
- Sars-Cov-2 infection
- hospital admission (emergency department, inpatient or ICU)
- hypoxemic respiratory failure, defined as P/F ratio below or including 200
Exclusion
- hypercapnia (PCO2 \> 45 mmHG in combination with acidemia (pH \< 7.35))
- pregnancy
- do not resuscitate order
Key Trial Info
Start Date :
September 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2023
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT06033560
Start Date
September 6 2022
End Date
November 1 2023
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC
Rotterdam, South Holland, Netherlands, 3015GD